James J Rahal

Summary

Affiliation: New York Presbyterian Hospital
Country: USA

Publications

  1. ncbi request reprint Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites
    James J Rahal
    Infectious Disease Section, New York Hospital Queens, Flushing, NY, 11355, USA
    Clin Infect Dis 34:499-503. 2002
  2. doi request reprint Antimicrobial resistance among and therapeutic options against gram-negative pathogens
    James J Rahal
    Infectious Disease Section, New York Hospital Queens, 56 45 Main St, Flushing, NY 11355, USA
    Clin Infect Dis 49:S4-S10. 2009
  3. ncbi request reprint Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species
    James J Rahal
    Infectious Disease Section and Lang Research Center, New York Hospital Queens, and Department of Medicine, Weill College of Medicine, Cornell University, New York, New York 11355 5095, USA
    Clin Infect Dis 43:S95-9. 2006
  4. pmc The role of carbapenems in initial therapy for serious Gram-negative infections
    James J Rahal
    Infections Disease Section, New York Hospital Queens, 56 95 Main Street, Flushing, NY 11355, USA
    Crit Care 12:S5. 2008
  5. ncbi request reprint Effect of interferon-alpha2b therapy on St. Louis viral meningoencephalitis: clinical and laboratory results of a pilot study
    James J Rahal
    Infectious Disease Section, Department of Medicine, New York Hospital Queens, 56 45 Main Street, Flushing, NY 11355, USA
    J Infect Dis 190:1084-7. 2004
  6. pmc In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli
    Carl Urban
    Infectious Disease Section, New York Hospital Queens, Flushing, New York, USA
    Antimicrob Agents Chemother 54:2732-4. 2010
  7. doi request reprint Identification of CTX-M beta-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities
    Carl Urban
    Infectious Disease Section, New York Hospital Queens, Flushing, NY 11355, USA
    Diagn Microbiol Infect Dis 66:402-6. 2010
  8. doi request reprint Identification of CTX-M β-lactamases among Escherichia coli from the community in New York City
    Hemavarna Tiruvury
    Infectious Disease Section, New York Hospital Queens, Flushing, NY 11355, USA
    Diagn Microbiol Infect Dis 72:248-52. 2012
  9. ncbi request reprint Increased mortality associated with a clonal outbreak of ceftazidime-resistant Klebsiella pneumoniae: a case-control study
    Abdul Qavi
    Infectious Disease Section, Department of Medicine, New York Hospital Medical Center of Queens, Flushing, New York 11355, USA
    Infect Control Hosp Epidemiol 26:63-8. 2005
  10. doi request reprint Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities
    Carl Urban
    Infectious Disease Section, New York Hospital Queens, Flushing, New York 11355, USA
    Clin Infect Dis 46:e127-30. 2008

Collaborators

Detail Information

Publications25

  1. ncbi request reprint Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites
    James J Rahal
    Infectious Disease Section, New York Hospital Queens, Flushing, NY, 11355, USA
    Clin Infect Dis 34:499-503. 2002
    ..Strategies appropriate for primary prevention of nosocomial resistance may differ from those required for control of existing epidemic or endemic resistance...
  2. doi request reprint Antimicrobial resistance among and therapeutic options against gram-negative pathogens
    James J Rahal
    Infectious Disease Section, New York Hospital Queens, 56 45 Main St, Flushing, NY 11355, USA
    Clin Infect Dis 49:S4-S10. 2009
    ..Thus, doripenem may be valuable alone or in combination with other agents in the treatment of serious gram-negative infections...
  3. ncbi request reprint Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species
    James J Rahal
    Infectious Disease Section and Lang Research Center, New York Hospital Queens, and Department of Medicine, Weill College of Medicine, Cornell University, New York, New York 11355 5095, USA
    Clin Infect Dis 43:S95-9. 2006
    ..However, against infections with species resistant to all antibiotics, including polymyxins, novel combinations are the only remaining therapeutic option...
  4. pmc The role of carbapenems in initial therapy for serious Gram-negative infections
    James J Rahal
    Infections Disease Section, New York Hospital Queens, 56 95 Main Street, Flushing, NY 11355, USA
    Crit Care 12:S5. 2008
    ..This article reviews the role played by carbapenems in the initial treatment of serious Gram-negative infections and the potential effect of emerging resistance on this role...
  5. ncbi request reprint Effect of interferon-alpha2b therapy on St. Louis viral meningoencephalitis: clinical and laboratory results of a pilot study
    James J Rahal
    Infectious Disease Section, Department of Medicine, New York Hospital Queens, 56 45 Main Street, Flushing, NY 11355, USA
    J Infect Dis 190:1084-7. 2004
    ..Early initiation of IFN-alpha2b therapy may reduce the severity and duration of complications due to previously untreatable flavivirus meningoencephalitis. A prospective randomized controlled trial is warranted...
  6. pmc In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli
    Carl Urban
    Infectious Disease Section, New York Hospital Queens, Flushing, New York, USA
    Antimicrob Agents Chemother 54:2732-4. 2010
    ..Combinations with these antibacterials may provide a strategy for treatment of patients infected with such organisms...
  7. doi request reprint Identification of CTX-M beta-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities
    Carl Urban
    Infectious Disease Section, New York Hospital Queens, Flushing, NY 11355, USA
    Diagn Microbiol Infect Dis 66:402-6. 2010
    ..CTX-M beta-lactamases have emerged within our location, and detection of bacteria harboring these enzymes in the clinical microbiology laboratory remains problematic because molecular methods are needed for their identification...
  8. doi request reprint Identification of CTX-M β-lactamases among Escherichia coli from the community in New York City
    Hemavarna Tiruvury
    Infectious Disease Section, New York Hospital Queens, Flushing, NY 11355, USA
    Diagn Microbiol Infect Dis 72:248-52. 2012
    ..Patients with symptomatic bacteriuria received drugs to which the organisms were susceptible, and most had favorable outcomes. Timely recognition of such isolates could help physicians choose more appropriate antibacterial therapy...
  9. ncbi request reprint Increased mortality associated with a clonal outbreak of ceftazidime-resistant Klebsiella pneumoniae: a case-control study
    Abdul Qavi
    Infectious Disease Section, Department of Medicine, New York Hospital Medical Center of Queens, Flushing, New York 11355, USA
    Infect Control Hosp Epidemiol 26:63-8. 2005
    ..To determine risk factors for ceftazidime-resistant Klebsiella pneumoniae infection and the effect of ceftazidime-resistant K. pneumoniae infection on mortality during an isolated outbreak...
  10. doi request reprint Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities
    Carl Urban
    Infectious Disease Section, New York Hospital Queens, Flushing, New York 11355, USA
    Clin Infect Dis 46:e127-30. 2008
    ..The identification of these enzymes in patients staying in long-term care facilities should be of great concern to all components of health care systems...
  11. ncbi request reprint Impact of contact and droplet precautions on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus infection
    Ed Mangini
    Department of Medicine, Weill Cornell Medical College, New York, NY 11355, USA
    Infect Control Hosp Epidemiol 28:1261-6. 2007
    ..To evaluate the efficacy of contact and droplet precautions in reducing the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections...
  12. pmc Polymyxin-resistant clinical isolates of Escherichia coli
    Carl Urban
    Infectious Disease Section, New York Hospital Queens, Flushing, NY 11355, USA
    Antimicrob Agents Chemother 55:388-9. 2011
    ..Resistance to cationic peptides in E. coli is unusual, and testing for susceptibility to these agents should be performed...
  13. pmc Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistance
    Wehbeh Wehbeh
    Infectious Disease Section, Department of Medicine and Lang Research Center, New York Hospital Queens, 56 45 Main Street, Flushing, NY 11355, USA
    Antimicrob Agents Chemother 49:2495-7. 2005
    ..agalactiae bacteria were isolated from the same patient...
  14. ncbi request reprint Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii
    Carl Urban
    Infectious Disease Section, New York Hospital Queens, Flushing, New York 11355 5095, USA
    Clin Infect Dis 36:1268-74. 2003
    ..Published clinical results of therapy with these agents are reviewed, and in vitro evidence of synergy between them is presented that suggests that combination therapy should be studied for enhanced clinical activity...
  15. pmc In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii
    Jimmy Yoon
    Infectious Disease Section, New York Hospital Queens, Flushing, Department of Microbiology, Weill Medical College of Cornell University, New York, New York, USA
    Antimicrob Agents Chemother 48:753-7. 2004
    ..Future clinical studies using double and triple therapy with these antibacterials may provide an effective option against potentially lethal infection due to multiresistant Acinetobacter baumannii...
  16. ncbi request reprint Quinolone-resistant Haemophilus influenzae in a long-term care facility: clinical and molecular epidemiology
    Jawad Nazir
    Infectious Disease Section, New York Hospital Queens, Flushing, New York 11355, USA
    Clin Infect Dis 38:1564-9. 2004
    ..Emphasis on patient contact and respiratory isolation and placing colonized or infected patients in cohorts yielded a marked reduction in the prevalence of QRHI at LTCF-A...
  17. ncbi request reprint Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City
    Patricia A Bradford
    Wyeth Research, Pearl River, NY, USA
    Clin Infect Dis 39:55-60. 2004
    ..Carbapenem-resistant Klebsiella species possessing KPC-2 are endemic in New York City. This study documents the identification of an inhibitor-resistant TEM beta -lactamase in the United States...
  18. pmc Use of daptomycin for the treatment of methicillin-resistant coagulase-negative staphylococcal ventriculitis
    Mohamed Erritouni
    Division of Infectious Diseases, Department of Medicine, New York Hospital Queens, Flushing, NY 11355, USA
    Case Report Med 2012:593578. 2012
    ..2008), Stucki et al. (2007), Lee et al. (2008) and Wallace et al. (2009). We report here our experience in the treatment of an EVD-related infection...
  19. ncbi request reprint An outbreak of domestically acquired typhoid fever in Queens, NY
    James Yoon
    Infectious Disease Section, Department of Medicine, New York Hospital Queens, Flushing, NY, 11355, USA
    Arch Intern Med 164:565-7. 2004
    ..We report the clinical features of these 4 cases and review endemic typhoid fever, a diagnosis not likely to be considered in the United States absent a history of recent international travel...
  20. doi request reprint Identification of carbapenem-resistant klebsiella pneumoniae harboring KPC enzymes in New Jersey
    Tom Chiang
    Veteran Affairs New Jersey Health Care System, East Orange, New Jersey, USA
    Microb Drug Resist 13:235-39. 2007
    ..pneumoniae due to KPC enzymes can only be achieved by molecular methods, detection in the Clinical Microbiology Laboratory by routine methods will continue to be difficult, leading to dilemmas in treatment...
  21. pmc Quinolone-resistant Haemophilus influenzae in a long-term-care facility: nucleotide sequence characterization of alterations in the genes encoding DNA gyrase and DNA topoisomerase IV
    Xinying Li
    Public Health Research Institute, 225 Warren St, Newark, NJ 07103, USA
    Antimicrob Agents Chemother 48:3570-2. 2004
    ..Similarities among the resistant isolates, plus multiple differences with susceptible isolates, suggest clonal dissemination involving two resistant subclones...
  22. pmc Quinolone-resistant Haemophilus influenzae: determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacin
    Xinying Li
    Public Health Research Institute, 225 Warren St, Newark, NJ 07103, USA
    Antimicrob Agents Chemother 48:4460-2. 2004
    ..Successive mutations raised the mutant selection window. The wild-type selection window for garenoxacin, levofloxacin, and moxifloxacin was also measured...
  23. doi request reprint Health care-associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI Summit
    Marin H Kollef
    Washington University School of Medicine, St Louis, Missouri 63110, USA
    Clin Infect Dis 47:S55-99; quiz S100-1. 2008
    ....
  24. ncbi request reprint Mycobacterial infection as a precursor to sarcoid-like, corticosteroid-responsive, diffuse granulomatous disease
    Christian Terzian
    Int J Infect Dis 10:407-8. 2006
  25. pmc Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro
    John F Anderson
    Emerg Infect Dis 8:107-8. 2002